Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer.
Zhang D, Hu Q, Liu X, Ji Y, Chao HP, Liu Y, Tracz A, Kirk J, Buonamici S, Zhu P, Wang J, Liu S, Tang DG.
Zhang D, et al. Among authors: liu y, liu x, liu s.
Nat Commun. 2020 Apr 29;11(1):2089. doi: 10.1038/s41467-020-15815-7.
Nat Commun. 2020.
PMID: 32350277
Free PMC article.